| Name | FTX-6058 | 
|---|
| Description | FTX-6058 is a potent and orally active inhibitor of Embryonic Ectoderm Development (EED). FTX-6058 can induce HbF protein expression in cell and murine models. FTX-6058 can be used for the research of select hemoglobinopathies, including sickle cell disease and β-thalassemia[1][2]. | 
|---|---|
| Related Catalog | |
| In Vitro | FTX-6058 inhibits PRC2 via binding to EED, which induces robust HbF protein expression in both cell and murine models[2]. | 
| References | [1]. Boerner LK. Virtual meeting delivers first time drug structures. April 12, 2021. | 
| Molecular Formula | C22H18FN5O2 | 
|---|---|
| Molecular Weight | 403.41 |